J&J reported 25.86 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
AbbVie 23.45 0.51 Sep/2026
Abbott 34.85 10.99 Sep/2026
Amgen 18.6 0.53 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Baxter International 20.35 131.6 Sep/2026
Bayer 4.61 0.47 Sep/2026
Becton, Dickinson and Co. 20.8 4.77 Sep/2026
Biogen 29.15 5.92 Sep/2026
Boston Scientific 15.51 2.35 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
CONMED 8.52 0.87 Jun/2026
Cooper Companies 24.8 1.53 Jun/2026
Dexcom 31.31 6.7 Sep/2026
Edwards Lifesciences 51.38 20.61 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Globus Medical 20.95 1.36 Sep/2026
Insulet 21.28 8.38 Sep/2026
Integra LifeSciences 8.02 2.26 Sep/2026
Intuitive Surgical 42.19 2.41 Sep/2026
J&J 25.86 3.57 Sep/2026
Medtronic 18.15 1.51 Jun/2026
Merck 34.36 2.11 Sep/2026
Merit Medical Systems 31.16 1.27 Sep/2026
Novartis 19.17 3.24 Sep/2026
Pfizer 15.2 3.72 Sep/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
Stryker 80.48 53.02 Sep/2026
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teva Pharmaceutical Industries 18.7 5.9 Sep/2026
Vertex Pharmaceuticals 29.35 1.3 Sep/2026
Zimmer Biomet Holdings 21.56 4.23 Sep/2026
Zoetis 11.38 0.8 Sep/2026